Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.
It’s unclear why Tallahassee Memorial HealthCare dropped its lawsuit, but it did so with prejudice, meaning the hospital cannot refile. There are many unanswered questions surrounding the unusual case, including how common incidents like this are and whether or not the hospital can technically bill for the time the room was occupied.
The new agentic program, called “Avery,” is now available to millions of UnitedHealthcare members through insurer's existing app. The company said the model will help patients find providers, understand their benefits, get updates on claims and more.
With roughly a third of all Medicare beneficiaries, or 20 million people, enrolled in a Medicare Advantage (MA) plan, new entrants into the healthcare field are eyeing this hefty population. And retail giant Walmart is no exception, according to Forbes.
When a medical device is recalled, the “why,” in the most general terms, is obvious—something is defective. But new research further examines what goes into recall decisions, finding product managers often rely on physicians to find problems with devices. Additionally, device suppliers can be less likely to issue a recall until the cause of the defect is discovered, which can reduce recall costs.
When compared to an FDA-regulated baby monitor, two smartphone-integrated consumer monitors performed inconsistently and displayed incorrectly low pulse rates, according to a Aug. 21 research letter published in JAMA.
In fiscal year 2017, the Medicaid program doled out about $37 billion in improper payments, an increase from $29.1 billion in improper payments recorded in 2015, according to a report from the Government Accountability Office.
One Medical Group, a primary care group with offices in San Francisco, New York, Seattle and other cities, has closed a $350 million investment from the Carlyle Group, a private equity group based in Washington, D.C., TechCrunch reported.
